Heavy Attack! The 9th BTE International Biotechnology Conference and Exhibition in 2025

COTV GLOBAL LIVE

The 9th BTE International Biotechnology Conference and Exhibition

The 9th International Bio-technology Conference & Expo

June 16-18, 2025 Guangzhou Canton Fair Exhibition Hall, Zone B

Biopharmaceuticals, cell therapy, in vitro diagnostics, genetic technology, medical testing

Host organization

Protein Medicine Research Association

Guangdong Biotechnology Industry Association

Guangzhou Pharmaceutical Industry Association

Zhenwei International Exhibition Group

Organizational structure

Guangzhou Zhenwei International Exhibition Co., Ltd

Zhenwei International Exhibition Group was founded in 2000 and was listed on the New Third Board on November 24, 2015 (stock code 834316). It is the largest private exhibition company in China, a member of the National Standardization Technical Committee for the Exhibition Industry, the exhibition organization with the most UFI International Exhibition Industry Association certifications in China, and a vice president unit of the China Exhibition Economy Research Association. According to the authoritative "Report on the Development of China's Exhibition Economy (2018)" released by the China Council for the Promotion of International Trade in 2019, the number of exhibitions held by Zhenwei Exhibition ranks first among domestic exhibition organizers. The BTE International Biotechnology Conference, hosted by Zhenwei International Exhibition Group, has gained a great reputation in the industry after 8 years of accumulation.

BTE 2025 Annual International Biotechnology Conference

The 9th BTE International Biotechnology Conference and Exhibition (BTE 2025) is an annual biotechnology industry event in the Guangdong Hong Kong Macao Greater Bay Area, focusing on cutting-edge technologies and applications in biopharmaceuticals, cell therapy, in vitro diagnostics, gene technology, medical testing, and other fields. It has formed a scale and great influence, and is expected to have more than 300 domestic and foreign brand enterprises, 25000+visitors, and multiple summit forums will be held at the same time.

We are committed to creating a high-level technological innovation carrier and platform through collaborative development, exchange, and integration of the biotechnology industry cluster in the Guangdong Hong Kong Macao Greater Bay Area. To make positive contributions to accelerating the cultivation of new quality productivity in the field of biotechnology.

Co create a feast of ideas and build a technological carrier together

BTE 2025 will continue to adhere to the exhibition mode of "meeting leads exhibition", focusing on the efficient integration of technology application and ideological theory, and emphasizing the improvement of the innovation capability and industrialization level of the biotechnology industry. Multiple dimensions will be encouraged to fully showcase innovative industries. At the same time, around topics such as innovative drugs, progress in ADC drug research and development, development of key pathogen vaccines, cell therapy, gene therapy, 3D cell culture and organoids, high-throughput sequencing technology, tumor markers, targeted and cellular immunotherapy, new developments in molecular diagnosis research and development, development of pathogen mNGS and tNGS detection technology, and research progress in disease biomarkers, authoritative figures from national government agencies, executives from domestic and foreign pharmaceutical and biotechnology companies are invited to share the latest industry information on policy needs, technological research, and industry planning. We sincerely invite you to witness the annual event of the South China biotechnology industry together!

[Guest Interview]

Dr. Li Yuling, President/Founder of Zhejiang Jianxin Force Pharmaceutical Co., Ltd

Currently, governments across the country deeply recognize that biomedicine and innovative drugs are a promising sunrise industry. Despite facing some challenges in the market and industry, the support for biopharmaceutical innovation in Guangdong Province and the Guangdong Hong Kong Macao Greater Bay Area is particularly prominent. From talent introduction, technical support to regulatory guidance, these policies are crucial for promoting the development of the industry. Pharmaceutical manufacturing is a complex system engineering that requires significant resource investment, professional talent, and advanced software and hardware facilities, as well as strict regulatory guidance. We urgently look forward to the Greater Bay Area providing more exchange platforms like the BTE International Biotechnology Conference. We need a lot of opportunities for communication, exploration, joint support, and collaborative growth to catch up with the world and lead the industry.

Ruan Jianxing, Marketing Director of Zhejiang Beilanbo Biotechnology Co., Ltd

In the past few years, we have been actively participating in the BTE Biotechnology Exhibition, which has become an important platform for us to showcase our latest technologies and products, giving us the opportunity to have in-depth product exchanges with many peers. Many industry experts came to this exhibition, and as a manufacturer, we attach great importance to communication with them. This not only helps us understand the latest developments in the industry, but also provides us with valuable opportunities for comparison and learning. Through these exchanges, we can obtain advanced industry information, which is crucial for our product improvement and innovation.

Wang Xinxin, R&D Manager of Shenzhen Kangkang Biopharmaceutical Technology Co., Ltd

The on-site crowd at this exhibition exceeded our expectations, and many visitors showed strong interest in our products. We also had in-depth exchanges with many familiar partners and met many new companies and products. This not only enhances the visibility of our company, but also provides us with valuable opportunities to communicate with peers. We attach great importance to collaboration with upstream and downstream enterprises, and this exhibition is undoubtedly an excellent platform for establishing new connections and strengthening old ones.

Wu Zhaopeng, CEO of Kejingda Biotechnology Co., Ltd

We are a Hong Kong based biotechnology company that showcased our independently developed surface plasmon resonance biosensor at the BTE Biotechnology Exhibition. It is the world's first and can reduce chip costs by one tenth. We hope to benefit patients through this cheaper and more accurate measurement technology. We hope that our product can obtain the national NMPA medical device certification and promote it to the public testing market. The atmosphere of this year's exhibition was very lively, and many industry experts and colleagues came to the scene to exchange ideas with us. We believe that through such an exhibition, our products will be able to gain wider application and recognition in China.

[Event topic]

（1） Molecular Diagnosis and Companion Diagnosis Summit Forum

Research progress on the regulatory mechanism of CRISPR/Cas12a cleavage activity and related detection techniques

Application and significance of autoantibodies in early diagnosis of cancer

Progress in Synthetic Library Nanoantibodies and Study on GPC-3 Molecular Detection Methods

New progress and clinical application of molecular diagnostic technology

Strategies and progress of cervical cancer screening triage

Clinical Practice and Reflection on the New Diagnosis and Treatment Model of Tumor MTB

（2） Forum on the Progress of Innovative Biopharmaceuticals and Cell Therapy

Development and Challenges of a New Generation of Personalized Tumor Treatment Products

Cell biomimetic culture technology and solution for scaling up culture process of adherent cells

Challenges and overall solutions for GMP production and construction of cell and gene therapy

Clinical value oriented CAR-T product development strategy

Frontier progress in TIL cell drug development

InnoRDC - Precision Targeted Therapy for Advanced Cancer Patients

How to break through material limitations, introduce quantum measurement technology, and empower clinical research innovation

Construction ideas for the standardization system of cell industrialization

（3） Antibody Drugs and New Drug Development Innovation Forum

New generation drug development based on antibody and non antibody derived scaffolds

Simplifying processes and reducing pollution - a new trend in the production of injection formulations

Research and cooperation on innovative ADC and self immunotherapy drugs

New technology equipment for milligram level separation and preparation of CE-SDS and icIEF protein antibody components

Exploring opportunities for gene therapy for retinal neovascularization diseases

Light quantum surface plasmon resonance biosensing technology

Opportunities for Chinese (life science) enterprises to enter the EU market

Regulatory considerations and lifecycle management of antibody pharmaceutical research

（4） Shenzhen Pingshan Biomedical Industry Accelerator Park Investment Cooperation Promotion Conference

Investment Strategy of Shenzhen Biomedical Industry Fund

Promotion and Investment Promotion of the Pharmaceutical and Medical Device Industry in Pingshan District

International Trends in New Drug Development and Opportunities for Going Global

Promotion of Pingshan Biomedical Industry Accelerator Park

（5） Seminar on "Shared Vision for a Better World: Standards for Sustainable Development"

Big Data Meets Life Sciences - Data Standardization

Aerogel technology and product standardization application scheme

Application of Gene Sequencing Standardization in Chronic Disease Prevention

Deep learning technology combines protein design from scratch for cell magnetic sorting

Economic decision-making based on data analysis

ESG Standardization Trend Response and Practical Case Analysis

Opportunities and challenges of the "the Belt and Road" standardization cooperation project

[Display Content]

Laboratory technology and equipment

Cell culture systems, biochemical analysis instruments, biological imaging systems, biochips HPLC、 Separation and purification system, reagents, accessories and consumables, laboratory information management system GLP/GMP、 Disinfection and clean room equipment, etc.

U Biotechnology Services

Genetic testing, stem cell technology, microbiology, molecular biology, cell biology services, biochar services CRO/CMO、 Technical training services, immunology services, staffing services, proteomics and metabolomics, biotechnology platform services, testing services, bioinformatics services, drug development and production services, clinical research services, etc.

Engineering and technical equipment

Fermentation tanks, cell reactors, cell culture equipment, saccharification equipment, separation and filtration, extraction and purification, instrumentation and industrial automation equipment, sanitary grade fluid equipment, environmental protection technology and equipment, etc.

Biological products and emerging therapies

Recombinant proteins, peptides, nucleic acids, vaccines, blood products, therapeutic antibodies, cell and gene therapy, tumor immunotherapy, stem cells&iPS, biopharmaceutical raw materials, active pharmaceutical ingredients, enzymes, auxiliary materials, additives, stabilizers, testing kits, etc.

Medical testing and IVD

Diagnostic instruments, reagents, auxiliary equipment, and supplies in the fields of biochemical diagnosis, immunological diagnosis, molecular diagnosis, microbiological diagnosis, urine diagnosis, cytological diagnosis, and POCT.

Quality Control and Safety

Quality management analysis, particle measurement equipment, comprehensive evaluation system, sugar chain/carbohydrate analysis system, viscometer, stability evaluation equipment, amino acid analysis system, etc.

[Contact Information]

BTE International Biotechnology Conference Organizing Committee

Room 405, Fengpu Technology Plaza, No. 2433 Xingang East Road, Haizhu District, Guangzhou City

Guangzhou Zhenwei International Exhibition Co., Ltd

Exhibition and conference registration contact: Gongmanager( gong man )

Mobile: 13710163299 (same WeChat number)

Phone: 020-83953215